The Effect of Motivational Interviewing With Video Call in Individuals With Type 2 Diabetes:RCT

Study Overview
=================
Brief Summary
-----------------
This study will be carried out to examine the effect of motivational interviewing applied by video call on diabetes self-efficacy, diabetes self-management and metabolic control parameters (HbA1c%, BMI, fasting glucose, cholesterol, blood pressure, waist circumference) in individuals with type 2 diabetes.

Official Title
-----------------
The Effect of Motivational Interviewing With Video Call on Diabetes Self-Efficacy, Diabetes Self-Management and Metabolic Control Parameters in Individuals With Type 2 Diabetes: A Randomized Controlled Study

Conditions
-----------------
Type2 Diabetes, Self Efficacy, Self Management, Video Call, HbA1c, BMI, Blood Pressure, Fasting Glucose, Cholesterol Deposition

Intervention / Treatment
-----------------
* Behavioral: Motivational Interviewing with WhatsApp video call


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Those between the ages of 30-64 Receiving insulin therapy Diagnosed with type 2 diabetes at least six months ago BMI value of 25 and above HbA1c of 8 and above (poor control) At least primary school graduate and can speak Turkish No communication barrier (speech, vision or hearing problem) Having a smart phone and internet access Individuals who agree to participate in the research. Exclusion Criteria: Communication disability (speech, vision or hearing problem) Those with neuropathy at a level that prevents them from doing their daily physical activities Diagnosed with kidney failure (acute or chronic) Pregnant Those with a diagnosis of cancer

Ages Eligible for Study
-----------------
Minimum Age: 30 Years
Maximum Age: 64 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: This study is a parallel group randomized controlled study.
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention Group<br> | Behavioral: Motivational Interviewing with WhatsApp video call<br>* The individuals in the intervention group will be given a motivational interview with a WhatsApp video call for 3 months. Motivational interview will be applied every two weeks, 6 times in total.<br>|
| No Intervention: Control Group<br>The control group received routine nursing care in the internal diseases policlinic. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Diabetes Self-Efficacy Scale | The change in diabetes self efficacy of individuals with Type 2 diabetes at 3rd month and 6 rd month with the Diabetes Self-Efficacy Scale. | Change from Baseline diabetes self-efficacy at 6 months | 
| Diabetes Self-Management Scale | This scale was used to measure the behavioral component of individuals in the IMB model. The validity and reliability study of the Turkish Diabetes Self-Management Perception Scale was conducted by Eroğlu and Sabuncu (2018). The scale consists of 16 items and 4 sub-dimensions and is a 4-point Likert type. Glucose Management sub-dimension: Items 4, 6, 10, 12 (items 4 and 12 are about drug use, items 1, 6 and 10 are about blood glucose monitoring). Diet Control sub-dimension: Items 2, 5, 9, 13. Physical Activity sub-dimension: Items 8, 11, 15. Use of Health Services sub-dimension: It consists of 3, 7, 14, and 16 items. The DMS scale consists of 16 items, 7 of which are straight and 9 of which are reversed. The scores of the items numbered 5, 7, 10, 11, 12, 13, 14, 15 and 16 in the scale are calculated by reversing them. Diabetes self-management increases as the score gets closer to 10. | Change from Baseline diabetes self-management at 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| HbA1c% |  | Change from Baseline HbA1c% at 6 months | 
| Body Mass Index |  | Change from Baseline Body Mass Index at 6 months | 
| Fasting glucose |  | Change from Baseline Fasting glucose at 6 months | 
| Cholesterol |  | Change from Baseline Cholesterol at 6 months | 
| waist circumference |  | Change from Baseline waist circumference at 6 months | 
| Blood pressure |  | Change from Baseline blood pressure % at 6 months |